A new national standard for cancer testing in England and Wales (NICE ‘Diagnostic Guidance 42’) was published in October 2020, following a successful policy engagement campaign from Professor Emma Crosbie’s team at The University of Manchester, and Policy@Manchester. In this piece, adapted from our On Cancer publication, Professor Crosbie explains why this is just the […]
Data directly from our patients: Is improving patient data the key to better cancer care?
To provide the best care and support for cancer patients during and after treatment, it is essential to collect and work with data that captures patient experiences and patient-reported outcomes. But data is not a simple subject. The way healthcare services work with data, and how we work with patients to collect it, must be […]
Advanced radiotherapies: What are the challenges and opportunities?
Advanced radiotherapies are redefining the kinds of cancer treatment that are possible. These developments are exciting, but they also present new challenges. One challenge for researchers and clinicians is how to support policymakers, tasked with developing treatment and care standards across the NHS. So, what are these new treatments, what do they mean for patient […]